SG10202102509TA - Micrornas as biomarkers for endometriosis - Google Patents

Micrornas as biomarkers for endometriosis

Info

Publication number
SG10202102509TA
SG10202102509TA SG10202102509TA SG10202102509TA SG10202102509TA SG 10202102509T A SG10202102509T A SG 10202102509TA SG 10202102509T A SG10202102509T A SG 10202102509TA SG 10202102509T A SG10202102509T A SG 10202102509TA SG 10202102509T A SG10202102509T A SG 10202102509TA
Authority
SG
Singapore
Prior art keywords
micrornas
endometriosis
biomarkers
Prior art date
Application number
SG10202102509TA
Inventor
Hugh Taylor
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Publication of SG10202102509TA publication Critical patent/SG10202102509TA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/364Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity
SG10202102509TA 2016-08-30 2017-08-30 Micrornas as biomarkers for endometriosis SG10202102509TA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662381130P 2016-08-30 2016-08-30

Publications (1)

Publication Number Publication Date
SG10202102509TA true SG10202102509TA (en) 2021-04-29

Family

ID=61301726

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201901834WA SG11201901834WA (en) 2016-08-30 2017-08-30 Micrornas as biomarkers for endometriosis
SG10202102509TA SG10202102509TA (en) 2016-08-30 2017-08-30 Micrornas as biomarkers for endometriosis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201901834WA SG11201901834WA (en) 2016-08-30 2017-08-30 Micrornas as biomarkers for endometriosis

Country Status (11)

Country Link
US (3) US10982282B2 (en)
EP (1) EP3506912B1 (en)
JP (2) JP2019528081A (en)
KR (1) KR20190057305A (en)
CN (1) CN109890394A (en)
AU (1) AU2017319325A1 (en)
BR (1) BR112019004075A2 (en)
CA (1) CA3035429A1 (en)
MX (1) MX2019002425A (en)
SG (2) SG11201901834WA (en)
WO (1) WO2018044979A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017319325A1 (en) 2016-08-30 2019-03-21 Yale University Micrornas as biomarkers for endometriosis
WO2019046494A1 (en) * 2017-08-30 2019-03-07 Dot Laboratories, Inc. Methods and compositions for detecting and treating endometriosis
EP3820483A4 (en) * 2018-07-13 2023-03-01 Yale University Compositions and methods for treating endometriosis
KR102089559B1 (en) * 2018-08-31 2020-03-16 차의과학대학교 산학협력단 Biomarker for diagnosing or predicting reactivity to FSH of ovary
US11315660B2 (en) 2018-10-31 2022-04-26 Dot Laboratories, Inc. Method of detecting and treating endometriosis in a female subject
CA3118133A1 (en) * 2018-10-31 2020-05-07 Yale University A quantitative algorithm for endometriosis
WO2020146544A1 (en) * 2019-01-09 2020-07-16 Research Institute At Nationwide Children's Hospital A novel method for monitoring endometriosis and associated disorders
EP3936614A1 (en) 2019-03-07 2022-01-12 Toray Industries, Inc. Kit, device, and method for detecting uterine leiomyosarcoma
ES2787725A1 (en) * 2019-04-15 2020-10-16 Univ Granada METHOD OF OBTAINING USEFUL DATA TO DIAGNOSE HEREDITARY HEMORRHAGIC TELANGIECTASIA (Machine-translation by Google Translate, not legally binding)
CN110144394A (en) * 2019-04-18 2019-08-20 辽宁省肿瘤医院 A kind of Diagnosis of Endometriosis, prognostic marker and its application
CN114144674A (en) * 2019-07-22 2022-03-04 豪夫迈·罗氏有限公司 Substance P as a blood biomarker for the non-invasive diagnosis of endometriosis
KR20220024782A (en) * 2019-07-22 2022-03-03 에프. 호프만-라 로슈 아게 S100A8 as a blood biomarker for non-invasive diagnosis of endometriosis
US11965879B2 (en) 2019-08-23 2024-04-23 Mcmaster University Method for diagnosing and assessing endometriosis
KR102242639B1 (en) * 2020-01-28 2021-04-21 고려대학교 산학협력단 Biomaker miRNA4668-5p for diagnosing liver fibrosis
KR102316507B1 (en) * 2020-02-28 2021-10-22 차의과학대학교 산학협력단 Biomarker for Ovarian reserve and use thereof
CN111909997B (en) * 2020-09-09 2021-09-28 上海交通大学 Application of miRNA marker in preparation of product for evaluating curative effect of olanzapine on schizophrenia treatment and kit

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009143181A2 (en) 2008-05-19 2009-11-26 The Regents Of The University Of California Micro-rna profile in human saliva and its use for detection of oral cancer
CN107254538A (en) 2008-11-12 2017-10-17 卡里斯生命科学瑞士控股有限责任公司 The method and system of phenotype is determined using allochthon
AU2011223789A1 (en) * 2010-03-01 2012-09-20 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
AU2012211272A1 (en) * 2011-01-26 2013-08-15 Cepheid Methods of detecting lung cancer
EP2675914A1 (en) * 2011-02-18 2013-12-25 Yale University, Inc. The kras-variant and endometriosis
FR2984358A1 (en) * 2011-12-16 2013-06-21 Genethon METHODS FOR THE DIAGNOSIS OF MUSCLE DYSTROPHIES
WO2013148151A1 (en) 2012-03-29 2013-10-03 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Plasma microribonucleic acids as biomarkers for endometriosis and endometriosis-associated ovarian cancer
CA2931082C (en) * 2013-11-18 2024-01-23 Diamir, Llc Methods of using mirnas from bodily fluids for detection and monitoring of parkinson's disease (pd)
GB201403489D0 (en) * 2014-02-27 2014-04-16 Univ London Queen Mary Biomarkers for endometriosis
US9650676B2 (en) 2014-03-19 2017-05-16 University Of South Carolina Leukocyte MicroRNAS for use in diagnosis and treatment of endometriosis
WO2015148919A2 (en) 2014-03-27 2015-10-01 Yale University Circulating micrornas as biomarkers for endometriosis
EP2924126B1 (en) * 2014-03-28 2018-04-18 Tervisetehnoloogiate Arenduskeskus AS Method for using microRNA (miRNA) for detection of endometriosis
GB201603967D0 (en) * 2016-03-08 2016-04-20 Univ Birmingham Biomarkers of traumatic brain injury
AU2017319325A1 (en) 2016-08-30 2019-03-21 Yale University Micrornas as biomarkers for endometriosis
WO2019046494A1 (en) 2017-08-30 2019-03-07 Dot Laboratories, Inc. Methods and compositions for detecting and treating endometriosis
CA3118133A1 (en) 2018-10-31 2020-05-07 Yale University A quantitative algorithm for endometriosis
US11315660B2 (en) 2018-10-31 2022-04-26 Dot Laboratories, Inc. Method of detecting and treating endometriosis in a female subject
SG11202111117WA (en) 2019-04-29 2021-11-29 Univ Yale Classifiers for detection of endometriosis

Also Published As

Publication number Publication date
JP2022188086A (en) 2022-12-20
BR112019004075A2 (en) 2019-05-28
US10982282B2 (en) 2021-04-20
EP3506912A4 (en) 2020-08-19
US11220713B2 (en) 2022-01-11
US20210180134A1 (en) 2021-06-17
EP3506912A1 (en) 2019-07-10
EP3506912B1 (en) 2024-04-03
CN109890394A (en) 2019-06-14
WO2018044979A1 (en) 2018-03-08
KR20190057305A (en) 2019-05-28
AU2017319325A1 (en) 2019-03-21
MX2019002425A (en) 2019-08-16
JP2019528081A (en) 2019-10-10
US20220049312A1 (en) 2022-02-17
SG11201901834WA (en) 2019-03-28
US20190276893A1 (en) 2019-09-12
CA3035429A1 (en) 2018-03-08

Similar Documents

Publication Publication Date Title
SG10202102509TA (en) Micrornas as biomarkers for endometriosis
AU359933S (en) Automobile
PL3067559T3 (en) Inflator
GB201403489D0 (en) Biomarkers for endometriosis
ZA201706537B (en) Indicator for manual inflator
GB201401603D0 (en) Biomarkers
GB201420908D0 (en) Biomarkers
SG10202007262PA (en) Copanlisib biomarkers
SG10202007322PA (en) Copanlisib biomarkers
GB201614455D0 (en) Biomarkers
EP3122905A4 (en) Circulating micrornas as biomarkers for endometriosis
GB201404189D0 (en) Novel biomarkers
GB201500729D0 (en) Novel Biomarkers
GB201518332D0 (en) Vehicle counterweight
GB201416015D0 (en) Biomarker
GB2533850B (en) Rapid inflator
GB201512133D0 (en) Biomarkers
IL268770A (en) Aptamer as biomarkers
GB201510496D0 (en) Vehicle
GB201420239D0 (en) Biomarker
GB2533673B (en) An airbag
GB201519704D0 (en) Biomarkers
GB201516841D0 (en) Novel biomarker
GB201521446D0 (en) Biomarker
GB201513683D0 (en) Biomarkers